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We describe a case of lymphocytic choriomeningitis 
virus (LCMV) meningitis in a New York, NY, resident who 
had no apparent risk factors. Clues leading to the diagnosis 
included aseptic meningitis during winter and the ﬁ  nding of 
hypoglycorrachia and lymphocytosis in the cerebrospinal 
ﬂ  uid. LCMV continues to be an underdiagnosed zoonotic 
disease.
L
ymphocytic choriomeningitis virus (LCMV) belongs 
to the family Arenavirus and has been found in Eu-
rope, the Americas, Australia, and Japan. Arenaviruses 
are typically associated with rodents, which can become 
chronically infected. The viruses are zoonotic and trans-
missible to man. LCMV is primarily maintained in the 
common house mouse (Mus musculus and M. domesticus), 
but has also been reported among pet and research rodents, 
including hamsters and guinea pigs (1). The prevalence of 
LCMV in wild mice in the United States ranges between 
3.9% and 13.4% (2). Human cases demonstrate a fall-to-
winter predominance corresponding to the movement of 
rodents indoors (1). Limited data are available on human 
infections but serologic studies in Washington, DC, Bal-
timore, Maryland, and Birmingham, Alabama, identiﬁ  ed 
evidence of previous infections among 2%–10% of the 
population sampled (3). A study in a Washington, DC, 
military base found that 8%–11% of patients having a 
febrile neurologic illness between 1941 and 1958 were 
seropositive for LCMV(4)
Transmission occurs by inhalation (aerosol and 
droplet), fomites, or direct contact with excreta or blood 
from infected rodents. Human-to-human transmission has 
been reported during pregnancy from infected mothers to 
the fetus (5) and through solid organ transplantation (6). 
The incubation period is 1–2 weeks. Infections in persons 
with an intact immune system are often asymptomatic or 
result in a mild self-limiting illness including fever, chills, 
myalgia, and headache. Photophobia, anorexia, testicular or 
parotid pain, pharyngitis, and cough have also been noted 
(1). Leukopenia, thrombocytopenia, and mild liver function 
abnormalities are common and may last 1–3 weeks. Central 
nervous system invasion is seen only in a few patients 
either after an initial febrile illness or, less commonly 
without any early symptoms. During this neurologic phase, 
most patients have aseptic meningitis and a peripheral 
leukocytosis (1). Cerebrospinal ﬂ   uid (CSF) leukocyte 
cell counts often exceed 1,000/μL, and glucose levels are 
low. Infection is rarely fatal, although ascending paralysis, 
transverse myelitis, or encephalitis may develop (1).
Critical or even fatal outcomes from LCMV are 
usually associated with transplacental infections, and, 
more recently, solid organ transplantation. Congenital 
LCMV can result in hydrocephalus, chorioretinopathy, 
macrocephalopathy, or microcephalopathy and can mimic 
the classic TORCH (toxoplasmosis/Toxoplasma gondii, 
other infections, rubella, cytomegalovirus, herpes simplex 
virus) pathogens. In 1 study of 26 infants with congenital 
LCMV, 9/26 (35%) died and 10/16 (63%) survivors had 
severe neurologic sequelae (7). Transplacental infection 
presumably occurs after maternal viremia during the ﬁ  rst 
and second trimesters (8). In 2003 and 2005, the ﬁ  rst reports 
of infection after solid organ transplantation were reported 
in which 7 of 8 patients receiving LCMV-infected organs 
(kidney, liver, and lung) died (6). Therapy for LCMV 
is supportive, although limited data support the use of 
ribavirin in immunosuppressed patients. We report a case 
of meningitis caused by LCMV in New York City.
The Patient
A 49-year-old man (taxi driver) sought treatment dur-
ing the winter of 2009. He had a 7-day history of fever, 
chills, headache, nausea, vomiting, neck rigidity, general-
ized weakness, and paresthesias in his ﬁ  ngers. He denied 
recent travel or exposure to sick contacts. Medical history 
included a corneal transplant the previous year. His tem-
perature when admitted was 37.5°C. Physical examination 
identiﬁ  ed nuchal rigidity but was otherwise unremarkable. 
CSF showed leukocytes 871 cells/μL; erythrocytes 2 cells/
μL, with 93% lymphocytes and 7% monocytes; glucose 
32 mg/dL (serum glucose 93 mg/dL); and protein 185 mg/
dL. Results of a computerized axial tomography scan of 
the brain and chest radiograph were normal. A complete 
blood count and results of serum chemical tests and liver 
function tests were unremarkable. Blood cultures yielded 
no growth. CSF cultures for bacterial, fungal, and my-
cobacterial organisms were negative. Results for syphilis 
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rapid plasma reagin, cryptococcal antigen, and HIV test-
ing were negative.
Because of the patient’s hypoglycorrachia, pro-
nounced CSF leukocytosis, and negative CSF cultures, 
acute infection with LCMV was considered. Serum tested 
at a commercial laboratory was positive for LCMV (im-
munoglobulin [Ig] G titer >256 (reference  <16) and IgM 
titer 80 (reference <20) by immunoﬂ  uorescence assay. CSF 
collected on day 1 and serum collected on days 7 and 15 
was tested for LCM antibodies by the Centers for Disease 
Control and Prevention’s Special Pathogens Branch using 
ELISA. CSF and serum were both IgM and IgG positive 
and a 4-fold rise in acute-phase and convalescent-phase se-
rum titers indicated the patient had a recent infection with 
LCMV (Table). The patient improved with supportive care, 
recovered fully, and was discharged on day 12.
Conclusions
The incidence rate of LCMV infection in New York 
City is unknown. The disease is likely underdiagnosed 
because only a limited number of commercial laborato-
ries offer LCMV testing. Diagnosed cases of LCMV are 
often identiﬁ  ed because they are part of a larger outbreak. 
Since 1960, only 7 cases have been reported in the litera-
ture (8,9); all but 2 had had contact with rodents. Several 
large outbreaks have been reported, often associated with 
pet hamsters or laboratory mice or hamsters; 1 outbreak 
had >236 human cases (8). A total of 54 cases of congenital 
LCMV are cited in the literature, 34 since 1993 (5).
Our patient denied both hamster and mouse exposure. 
His corneal transplant had occurred >1 year before, and was 
unlikely to be the source of infection. A deﬁ  nitive diagno-
sis was difﬁ  cult, but testing by Centers for Disease Control 
and Prevention conﬁ  rmed the diagnosis. 
New York City Health Department ofﬁ  cials attempted 
an investigation of the patient’s home and surroundings to 
look for evidence of rodents or rodent excreta, but were 
unable to do so due to the patient’s noncompliance. Sev-
eral clues have assisted clinicians in the identiﬁ  cation of 
patients with acute LCMV infection: 1) aseptic meningi-
tis or encephalitis during the fall–winter season, 2) a fe-
brile illness followed by brief remission before onset of 
neurologic illness, and 3) CSF with a lymphocytosis and 
hypoglycorrachia. Patients with suspected LCMV should 
be asked about potential rodent exposure (1). Patients with 
a history of organ transplantation within the preceding 3 
months should be fully evaluated to determine whether in-
fected organs were the source of LCMV.
We recommend enzyme immunoassay-based testing of 
CSF and serum when LCMV is considered. Public health 
surveillance, rodent control, healthcare provider education, 
and improved laboratory testing can enhance recognition 
of illness.
Health departments should consider making LCMV a 
reportable condition, and, if aseptic meningitis is report-
able, questions should be added to case investigation forms 
regarding rodent exposure. LCMV was made reportable in 
New York City in 2009. Only with a better understanding 
of the true incidence of LCMV will authorities be able to 
enact measures to better prevent and control this disease in 
the vulnerable sections of our society.  
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